s-1743 and Clostridium-Infections

s-1743 has been researched along with Clostridium-Infections* in 1 studies

Trials

1 trial(s) available for s-1743 and Clostridium-Infections

Article	Year
The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study. Frontiers in cellular and infection microbiology, 2017, Volume: 7 Proton pump inhibitors (PPIs) are the standard therapy for gastroesophageal reflux disease. In adults, PPI treatment is associated with Topics: Clostridioides difficile; Clostridium Infections; Esomeprazole; Feces; Female; Gastroesophageal Reflux; Humans; Infant; Longitudinal Studies; Male; Microbiota; Prospective Studies; Proton Pump Inhibitors; Statistics, Nonparametric; Time Factors	2017

Article

Year

The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.

Frontiers in cellular and infection microbiology, 2017, Volume: 7

Proton pump inhibitors (PPIs) are the standard therapy for gastroesophageal reflux disease. In adults, PPI treatment is associated with

Topics: Clostridioides difficile; Clostridium Infections; Esomeprazole; Feces; Female; Gastroesophageal Reflux; Humans; Infant; Longitudinal Studies; Male; Microbiota; Prospective Studies; Proton Pump Inhibitors; Statistics, Nonparametric; Time Factors

2017